Emerging Strategies for Rheumatoid Arthritis
Medication Adherence and Attrition to Biologic Treatment in Rheumatoid Arthritis Patients
The objectives of this study were to assess medication adherence rate and attrition rate in first-time adalimumab (ADA) or etanercept (ETA) users in rheumatoid arthritis (RA) patients. This study also identified the risk factors associated with nonadherence and treatment abandonment.
